Works matching AU Toru Sugiyama

Results: 124
    1
    2

    Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

    Published in:
    International Journal of Clinical Oncology, 2010, v. 15, n. 6, p. 531, doi. 10.1007/s10147-010-0138-6
    By:
    • Nagase, Satoru;
    • Katabuchi, Hidetaka;
    • Hiura, Masamichi;
    • Sakuragi, Noriaki;
    • Aoki, Yoichi;
    • Kigawa, Junzo;
    • Saito, Tsuyoshi;
    • Hachisuga, Toru;
    • Ito, Kiyoshi;
    • Uno, Takashi;
    • Katsumata, Noriyuki;
    • Komiyama, Shinichi;
    • Susumu, Nobuyuki;
    • Emoto, Makoto;
    • Kobayashi, Hiroaki;
    • Metoki, Hirohito;
    • Konishi, Ikuo;
    • Ochiai, Kazunori;
    • Mikami, Mikio;
    • Sugiyama, Toru
    Publication type:
    Article
    3

    Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.

    Published in:
    International Journal of Clinical Oncology, 2007, v. 12, n. 4, p. 256, doi. 10.1007/s10147-007-0670-1
    By:
    • Takano, Masashi;
    • Sugiyama, Toru;
    • Yaegashi, Nobuo;
    • Suzuki, Mitsuaki;
    • Tsuda, Hiroshi;
    • Sagae, Satoru;
    • Udagawa, Yasuhiro;
    • Kuzuya, Kazuo;
    • Kigawa, Junzo;
    • Takeuchi, Satoshi;
    • Tsuda, Hitoshi;
    • Moriya, Takuya;
    • Kikuchi, Yoshihiro
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer.

    Published in:
    Oncology, 2002, v. 63, n. 1, p. 16, doi. 10.1159/000065715
    By:
    • Sugiyama, Toru;
    • Yakushiji, Michiaki;
    • Kamura, Toshiharu;
    • Ikeda, Masanori;
    • Umesaki, Naohiko;
    • Hasegawa, Kazuo;
    • Ishikawa, Mutsuo;
    • Saji, Fumitaka;
    • Hiura, Masamichi;
    • Takahashi, Takeshi;
    • Sato, Shinji;
    • Ochiai, Kazunori;
    • Kikkawa, Fumitaka;
    • Takeuchi, Shoshichi;
    • Ohashi, Yasuo;
    • Noda, Kiichiro
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.

    Published in:
    Journal of Gynecologic Oncology, 2020, v. 31, n. 6, p. 1, doi. 10.3802/jgo.2020.31.e94
    By:
    • Eiji Kondo;
    • Tsutomu Tabata;
    • Nao Suzuki;
    • Daisuke Aoki;
    • Hideaki Yahata;
    • Yoshio Kotera;
    • Osamu Tokuyama;
    • Keiichi Fujiwara;
    • Eizo Kimura;
    • Fumitoshi Terauchi;
    • Toshiyuki Sumi;
    • Aikou Okamoto;
    • Nobuo Yaegashi;
    • Takayuki Enomoto;
    • Toru Sugiyama
    Publication type:
    Article
    29
    30

    Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).

    Published in:
    Journal of Gynecologic Oncology, 2017, v. 28, n. 5, p. 1, doi. 10.3802/jgo.2017.28.e44
    By:
    • Shunsuke Ohnishi;
    • Hidemichi Watari;
    • Maki Kanno;
    • Yoko Ohba;
    • Satoshi Takeuchi;
    • Tempei Miyaji;
    • Shunsuke Oyamada;
    • Eiji Nomura;
    • Hidenori Kato;
    • Toru Sugiyama;
    • Masahiro Asaka;
    • Noriaki Sakuragi;
    • Takuhiro Yamaguchi;
    • Yasuhito Uezono;
    • Satoru Iwase
    Publication type:
    Article
    31
    32
    33
    34
    35

    Clinical characteristics of clear cell carcinoma of the ovary.

    Published in:
    Cancer (0008543X), 2000, v. 88, n. 11, p. 2584, doi. 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5
    By:
    • Sugiyama, Toru;
    • Kamura, Toshiharu;
    • Kigawa, Junzo;
    • Terakawa, Naoki;
    • Kikuchi, Yoshihiro;
    • Kita, Tunekazu;
    • Suzuki, Mitsuaki;
    • Sato, Ikuo;
    • Taguchi, Kouji
    Publication type:
    Article
    36

    Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study.

    Published in:
    Cancer Science, 2023, v. 114, n. 6, p. 2515, doi. 10.1111/cas.15747
    By:
    • Yoshihara, Kosuke;
    • Baba, Tsukasa;
    • Tokunaga, Hideki;
    • Nishino, Koji;
    • Sekine, Masayuki;
    • Takamatsu, Shiro;
    • Matsumura, Noriomi;
    • Yoshida, Hiroshi;
    • Kajiyama, Hiroaki;
    • Shimada, Muneaki;
    • Kagimura, Tatsuo;
    • Oda, Katsutoshi;
    • Sasajima, Yuko;
    • Yaegashi, Nobuo;
    • Okamoto, Aikou;
    • Sugiyama, Toru;
    • Enomoto, Takayuki
    Publication type:
    Article
    37

    Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023.

    Published in:
    Cancer Science, 2022, v. 113, n. 1, p. 240, doi. 10.1111/cas.15185
    By:
    • Shoji, Tadahiro;
    • Enomoto, Takayuki;
    • Abe, Masakazu;
    • Okamoto, Aikou;
    • Nagasawa, Takayuki;
    • Oishi, Tetsuro;
    • Nagase, Satoru;
    • Mori, Masahiko;
    • Inokuchi, Yuki;
    • Kamiura, Shoji;
    • Komiyama, Shinichi;
    • Takeshima, Nobuhiro;
    • Sugiyama, Toru
    Publication type:
    Article
    38
    39
    40
    41

    The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.

    Published in:
    2017
    By:
    • Takekuma, Munetaka;
    • Mori, Keita;
    • Iida, Tetsuji;
    • Kurihara, Kazuko;
    • Saitou, Motoaki;
    • Tokunaga, Hideki;
    • Kawana, Kei;
    • Ikeda, Masae;
    • Satoh, Toyomi;
    • Saito, Toshiaki;
    • Miyagi, Etsuko;
    • Nagai, Yutaka;
    • Furusawa, Akiko;
    • Kawano, Yoshiaki;
    • Kawano, Kouichiro;
    • Tabata, Tsutomu;
    • Ota, Yukinobu;
    • Hayase, Ryoji;
    • Mikami, Mikio;
    • Sugiyama, Toru
    Publication type:
    journal article
    42

    A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

    Published in:
    2017
    By:
    • Shoji, Tadahiro;
    • Takatori, Eriko;
    • Omi, Hideo;
    • Kagabu, Masahiro;
    • Honda, Tatsuya;
    • Futagami, Masayuki;
    • Yokoyama, Yoshihito;
    • Kaiho, Michiko;
    • Tokunaga, Hideki;
    • Otsuki, Takeo;
    • Takano, Tadao;
    • Yaegashi, Nobuo;
    • Kojimahara, Takanobu;
    • Ohta, Tsuyoshi;
    • Nagase, Satoru;
    • Soeda, Shu;
    • Watanebe, Takafumi;
    • Nishiyama, Hiroshi;
    • Sugiyama, Toru
    Publication type:
    journal article
    43
    44
    45
    46
    47
    48
    49
    50